Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.

Xue-Song SunBei-Bei XiaoChao LinSai-Lan LiuQiu-Yan ChenLin-Quan Tang Hai-Qiang Mai

Published in: Cancer medicine (2020)

Our nomograms are reliable prognostic predictors of PFS and OS in patients with stage II-IVa NPC. These nomograms could robustly estimate an individual's benefit from concurrent chemotherapy, which assists in treatment decision-making.

Keyphrases

locally advanced
risk factors
decision making
rectal cancer
squamous cell carcinoma
radiation therapy
chemotherapy induced
data analysis